RE: Morning all2 Sep 2025 19:53
Rerating has officially began here imho.
Can see a sustained rise to news and then it’ll probably spike even further up.
Loads of other small pharmas been doing the same.
That gap on the chart at 11p is reason I’m here.
Due news on Oncogeni deal also. Surely it’s gonna get over the line as they would have had to rns any material change to the terms ?
Nai/DYOR